Article
Author(s):
In the past decade, improved understanding of midface position and its relationship with the lower eyelid has changed not only our approach to cosmetic surgery, but also our approach toward lower eyelid malpositions.
Atsena Therapeutics and Nippon Shinyaku enter exclusive license agreement for ATSN-101
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Study examines the use of AI–based detection of diabetic retinopathy in the US
Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
MediPrint Ophthalmics reveals positive results from phase 2b study of LL-BMT1 contact lens
HuidaGene Therapeutics' IND application for HG202 for the treatment of nAMD cleared by FDA